ACUTAAS Acutaas Chemicals Q1 FY27 results (Apr–Jun 2026) and concall
Acutaas Chemicals Limited reported a strong Q1 FY27, with revenue growing 59.1% year-on-year to INR 329.7 crores, driven by robust performance in Advanced Pharmaceutical Intermediates (up 76.5%). Profitability saw significant expansion, with EBITDA increasing more than twofold to INR 113.1 crores and PAT rising 70.4% to INR 74.9 crores. The company successfully commenced commercial supply from its new battery chemicals plant and is progressing well on its semiconductor chemicals facility in Korea. While the Specialty Chemicals segment saw a 10.6% decline due to strategic phasing out of commodi
You’re reading a preview. Opening the full call uses 1 concall credit.
Sign in to use your monthly call allowance.
What they filed
Q1 FY27: revenue up 56.3%, net profit up 68.9% against the same quarter last year.
| Line item | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 | Q1 FY27 |
|---|---|---|---|---|---|---|---|
| Revenue | 271 | 304 | 206 | 305 | 391 +44% | 422 +39% | 322 +56% |
| EBITDA | 67 | 84 | 51 | 97 | 154 +130% | 181 +115% | 110 +116% |
| Net profit | 45 | 63 | 45 | 73 | 112 +149% | 137 +117% | 76 +69% |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.
